Spero Therapeutics Inc (SPRO)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current SPRO market cap is 69.18M. The company's latest EPS is USD 0.4219 and P/E is 3.01.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.72M | 25.47M | 73.52M | 9.27M | 10.2M |
| Operating Income | -12.89M | 3.37M | 50.53M | -13.98M | -19.06M |
| Net Income | -11.91M | -3.21M | 51.19M | -12.67M | -17.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.15M | 9.33M | 18.26M | 53.51M | 103.78M |
| Operating Income | -63.22M | -79.11M | -87.97M | -42.2M | 26.79M |
| Net Income | -60.93M | -78.28M | -89.76M | -46.42M | 22.81M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 98.89M | 107.1M | 182.39M | 167.7M | 149.88M |
| Total Liabilities | 44.1M | 53.4M | 75.5M | 71.45M | 69.38M |
| Total Equity | 54.78M | 53.71M | 106.89M | 96.25M | 80.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.1M | 153.45M | 171.07M | 124.8M | 182.39M |
| Total Liabilities | 31.53M | 21.41M | 82.78M | 48.87M | 75.5M |
| Total Equity | 74.57M | 132.04M | 88.29M | 75.93M | 106.89M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.42M | -15.5M | -33M | 5.94M | -12.81M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 220k | 221k | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -50.02M | -85.87M | -64.35M | -7.73M | -33M |
| Investing | 29.53M | 10.47M | 7.67M | 33.81M | N/A |
| Financing | 16.14M | 130.88M | 84.05M | -29.55M | 221k |
| Market Cap | 69.18M |
| Price to Earnings Ratio | 3.01 |
| Price to Sales Ratio | 0.66 |
| Price to Cash Ratio | 0.9 |
| Price to Book Ratio | 0.64 |
| Dividend Yield | - |
| Shares Outstanding | 54.05M |
| Average Volume (1 week) | 112.74k |
| Average Volume (1 Month) | 122.07k |
| 52 Week Change | 4.92% |
| 52 Week High | 1.89 |
| 52 Week Low | 0.99 |
| Spread (Intraday) | 0.02 (1.55%) |
| Company Name | Spero Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.sperotherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
